Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 165.10
+11.20 (7.28%)
Oct 14, 2026, 4:08 PM HKT
HKG:2637 Market Cap
HKG:2637 has a market cap or net worth of 12.99 billion as of October 14, 2026. It is the 7,803rd most valuable company in the world and the 401st biggest in Hong Kong.
Market Cap
12.99B
Enterprise Value
11.46B
Revenue
685.64M
Global Rank
Country Rank
#401 Hong Kong
PE Ratio
71.62
ChartMarket Cap Chart
Since October 20, 2025, HKG:2637's market cap has increased from 8.20B to 12.99B, an increase of 58.45%. That is a compound annual growth rate of 59.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 12.99B | 21.40% |
| Dec 31, 2025 | 10.70B | 30.52% |
| Oct 20, 2025 | 8.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunshine Lake Pharma | 22.78B |
| Grand Pharmaceutical Group | 16.48B |
| CanSino Biologics | 15.78B |
| The United Laboratories International Holdings | 14.63B |
| Consun Pharmaceutical Group | 12.75B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Shandong Xinhua Pharmaceutical Company | 9.29B |
| SSY Group | 7.89B |